Targeting by PG545 enhances PARP inhibitor response in ovarian cancer
![Targeting by PG545 enhances PARP inhibitor response in ovarian cancer](https://images.zapnito.com/cdn-cgi/image/metadata=copyright,fit=scale-down,format=auto,quality=95/https://images.zapnito.com/users/452629/posters/8322e5ec-10a9-4271-aa57-050c205e57a2_large.jpeg)
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41388-023-02785-5/MediaObjects/41388_2023_2785_Figa_HTML.png)
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
![](https://www.tandfonline.com/cms/asset/6a65f691-50cc-4db2-8f01-51802b7a21cb/iett_a_2266572_f0006_oc.jpg)
Full article: Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-022-04670-7/MediaObjects/41419_2022_4670_Fig2_HTML.png)
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
![](https://pub.mdpi-res.com/cancers/cancers-15-03220/article_deploy/html/images/cancers-15-03220-g001.png?1687146336)
Cancers, Free Full-Text
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-022-04670-7/MediaObjects/41419_2022_4670_Fig1_HTML.png)
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-022-04670-7/MediaObjects/41419_2022_4670_Fig6_HTML.png)
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
![](https://pub.mdpi-res.com/biomolecules/biomolecules-13-01306/article_deploy/html/images/biomolecules-13-01306-g002.png?1692947272)
Biomolecules, Free Full-Text
![](https://i.ytimg.com/vi/22Z1vDO6LIQ/maxresdefault.jpg)
One more step toward treatment of PARP inhibitor-resistant ovarian cancers
![](https://pub.mdpi-res.com/cancers/cancers-11-01678/article_deploy/html/images/cancers-11-01678-ag.png?1575011402)
Cancers, Free Full-Text
![](https://www.researchgate.net/publication/311583583/figure/fig6/AS:476930702090242@1490720548372/PARP-Inhibitors-Synergize-with-b-Lap-against-Orthotopic-MiaPaCa2-PDA-Xenografts-A-and-B.png)
PARP Inhibitors Synergize with b-Lap against Orthotopic MiaPaCa2 PDA
![](https://www.researchgate.net/publication/272191744/figure/fig4/AS:295062094270471@1447359693310/Synergistic-effects-of-PG545-and-gemcitabine-co-treatment-on-pancreatic-cancer-cells-A.png)
Synergistic effects of PG545 and gemcitabine co-treatment on pancreatic
![](https://www.frontiersin.org/files/Articles/795547/fonc-11-795547-HTML/image_m/fonc-11-795547-g001.jpg)
Frontiers Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
![](https://www.mdpi.com/biomolecules/biomolecules-13-01306/article_deploy/html/images/biomolecules-13-01306-g003.png)
Biomolecules, Free Full-Text
![](https://www.researchgate.net/publication/322961528/figure/fig5/AS:591083805376513@1517936769955/A-Co-treatment-of-QC-and-autophagy-inhibitor-Bafilomycin-A-in-C13-cells-C13-cells-were.png)
A) Co-treatment of QC and autophagy inhibitor Bafilomycin A in C13
![](https://images.zapnito.com/cdn-cgi/image/metadata=copyright,fit=scale-down,format=auto,quality=95/https://images.zapnito.com/tenants/46/badges/9586/brand_logo/large_Springer_Nature.jpg)
Targeting by PG545 enhances PARP inhibitor response in ovarian cancer